RESUMO
Introduction: Autoimmune disorders, IgA deficiency, and allergies seem to be common among individuals with 18q deletion syndrome [OMIM 601808]. We aimed to determine the prevalence, mechanism, and genetic background of autoimmunity, immune deficiency, and allergy in a cohort of patients with 18q deletions. Material and Methods: Medical registries and social media were used to recruit the patients. Microarray oligonucleotide comparative genomic hybridization (aCGH) (Agilent, Santa Clara, CA, USA) was performed in all patients to identify size and location of chromosome 18 deletion. Clinical evaluation and medical record collection were performed in each of the study participants. The history of autoimmune disorders, severe and/or recurrent infections, and symptoms of allergy were noted. Total immunoglobulin IgG, IgA, IgM, IgE, and IgG1-4 serum levels were measured using nephelometry and ELISA methods. Lymphocyte T subset phenotyping was performed in 24 subjects from 18q del cohort. To predict the most promising candidate genes, we used the ENDEAVOUR-a free web resource for gene prioritization. Results: 18q deletion was confirmed by means of array CGH analysis in 27 individuals, 15 (55.6%) females and 12 males, referred to the project by specialists in medical genetics, diabetology, or pediatric endocrinology between May 2015 and December 2019. The mean age at examination was 11.8 years (min-max: 4.0-33.5). Autoimmune disorders were present in 14/27 (51.8%) of the cohort. In eight of patients, symptoms of immune deficiency coexisted with autoimmunity. Allergy was reported in nine of 27 (33.4%) patients. Over 89% of patients presented with at list one type of immunoglobulin (IgA, IgM, IgG, IgE, and IgG1-4) deficiency and eight of 25 (32%) had abnormalities in at least two major immunoglobulin (IgG, IgA, IgM) measurements (CVID-like phenotype). Patients with 18q del exhibited a significantly decreased CD4, Treg FOXP3+, TregFOXP3+Helios+, and TemCD4 cell numbers in comparison with the control groups of 24 T1DM patients and 28 healthy controls. Conclusions: Patients with 18q deletions frequently suffer from autoimmune disorders, recurrent infections, and allergy due to immune dysregulation presenting with variable antibody deficiencies and T-regulatory cell deficiency (CD4+CD25+CD127lowFOXP3+). The spectrum of speculations regarding which gene might be responsible for such phenotype ranges from single gene haploinsufficiency to deletion of a cluster of immunogenes located distally to 18q21.
Assuntos
Autoimunidade/genética , Transtornos Cromossômicos/imunologia , Hipersensibilidade/genética , Síndromes de Imunodeficiência/genética , Adolescente , Adulto , Autoimunidade/imunologia , Criança , Pré-Escolar , Deleção Cromossômica , Cromossomos Humanos Par 18/imunologia , Estudos de Coortes , Feminino , Humanos , Hipersensibilidade/imunologia , Síndromes de Imunodeficiência/imunologia , Masculino , Adulto JovemRESUMO
BACKGROUND: Primary immunodeficiencies (PID) represent a heterogeneous group of genetic disorders characterised by poor or absent function in one or more components of the immune system. Humoral or antibody immunodeficiencies are the most common form of PID, of which common variable immunodeficiency (CVID) is the most frequent symptomatic form. CVID is usually characterised by hypogammaglobulinaemia with poor antibody specificity, and an increased susceptibility to infections, autoimmunity and lymphoproliferation. Fewer than 10% of CVID patients have a known monogenic basis. Several chromosomal abnormalities (chromosome 18q-syndrome, monosomy 22, trisomy 8 and trisomy 21) are currently identified as causes of hypogammaglobulinaemia, and can manifest with recurrent infections and mimic CVID. METHODS: Review of clinical charts and laboratory results of paediatric patients followed in the outpatient clinic of PID with a diagnosis of genetic disease and humoral immunodeficiency. RESULTS: Three patients with different genetic diseases (19p13.3 deletion, a ring 18 chromosome and Kabuki syndrome), were identified. During follow-up, they developed signs and symptoms suggestive of humoral deficiency mimicking CVID, despite which immunoglobulin levels were quantified with considerable delay with respect to symptoms onset, and specific management was subsequently delayed. CONCLUSIONS: Patients with genetic abnormalities and recurrent infections should be evaluated for hypogammaglobulinaemia. An early diagnosis of humoral deficiency can allow treatment optimisation to prevent complications and sequelae.
Assuntos
Anormalidades Múltiplas/imunologia , Deleção Cromossômica , Cromossomos Humanos Par 19/genética , Face/anormalidades , Doenças Hematológicas/imunologia , Imunidade Humoral/genética , Doenças Vestibulares/imunologia , Adolescente , Agamaglobulinemia/diagnóstico , Agamaglobulinemia/genética , Autoimunidade/genética , Criança , Cromossomos Humanos Par 18/imunologia , Cromossomos Humanos Par 19/imunologia , Imunodeficiência de Variável Comum/diagnóstico , Diagnóstico Diferencial , Feminino , Humanos , Imunoglobulinas Intravenosas , Masculino , Cromossomos em Anel , EspanhaAssuntos
Anticorpos Monoclonais Humanizados/uso terapêutico , Antirreumáticos/uso terapêutico , Artrite Juvenil/tratamento farmacológico , Transtornos Cromossômicos/imunologia , Adalimumab , Artrite Juvenil/diagnóstico , Artrite Juvenil/genética , Artrite Juvenil/imunologia , Criança , Deleção Cromossômica , Transtornos Cromossômicos/diagnóstico , Transtornos Cromossômicos/genética , Cromossomos Humanos Par 18/genética , Cromossomos Humanos Par 18/imunologia , Substituição de Medicamentos , Feminino , Predisposição Genética para Doença , Humanos , Fenótipo , Resultado do TratamentoRESUMO
OBJECTIVES: The contribution of local inflammation to the pathophysiology of abnormal choromosomally miscarriages remains unclear The objective of this study was to investigate the inflammatory response at the maternofetal interface of women presenting with first trimester miscarriage with abnormal choromosomally MATERIAL AND METHODS: Level of TNF-α , IL-6 ve IL-17 were asseyed using immunohistochemistry technique at decidual and placental bed biopsy samples from 23 women with elective termination of pregnancy 21 euploid and 18 aneuploid missed miscarriages. Immunostainig for TNF-α, IL-6 ve IL-17 has been evaluated semi-quantitatively by 'quickscore' method. RESULTS: We found that the intensity of TNF-α staining was high in the miscarriage group, and this has been found in previous studies. Unlike some previous studies, the intensity of IL-6 staining was higher in the miscarriage groups only in decidual glandular epithelium. The intensity of IL-6 staining was found to be higher in the miscarriage group with chromosome anomaly than in the miscarriage group without chromosome anomaly. There was no significant difference in IL-17 levels between any of the groups. CONCLUSIONS: Cytokines are considered to play an important role in the maintenance of pregnancy but the exact mechanism between them and the mutual regulation relationship were not been fully understood, which need our further study.
Assuntos
Aborto Espontâneo/imunologia , Cromossomos Humanos Par 21/imunologia , Síndrome de Down/imunologia , Interleucina-6/análise , Interleucina-8/análise , Trissomia/imunologia , Fator de Necrose Tumoral alfa/metabolismo , Cromossomos Humanos Par 18/imunologia , Feminino , Humanos , Imuno-Histoquímica , Gravidez , Primeiro Trimestre da Gravidez , Síndrome da Trissomía do Cromossomo 18Assuntos
Humanos , Masculino , Pré-Escolar , Imunoglobulina M/deficiência , Cromossomos Humanos Par 18/imunologia , Síndromes de Imunodeficiência/imunologia , Citometria por Imagem/métodos , Citometria por Imagem/tendências , Fatores Imunológicos/deficiência , Aberrações Cromossômicas , Tonsilectomia/tendências , Imageamento por Ressonância Magnética/métodos , Recidiva , Infecções Respiratórias/complicaçõesAssuntos
Transplante de Células-Tronco Hematopoéticas , Linfoma Folicular/mortalidade , Linfoma Folicular/terapia , Cromossomos Humanos Par 14/genética , Cromossomos Humanos Par 14/imunologia , Cromossomos Humanos Par 18/genética , Cromossomos Humanos Par 18/imunologia , Intervalo Livre de Doença , Feminino , Humanos , Linfoma Folicular/diagnóstico , Linfoma Folicular/genética , Linfoma Folicular/imunologia , Linfoma Folicular/patologia , Masculino , Proteínas Proto-Oncogênicas c-bcl-2/genética , Proteínas Proto-Oncogênicas c-bcl-2/imunologia , Taxa de Sobrevida , Translocação Genética/genética , Translocação Genética/imunologia , Transplante Homólogo , Estados Unidos/epidemiologiaRESUMO
X-linked hyper-IgM syndrome (XHIGM) is a primary immunodeficiency disorder (PID) caused by mutation in the gene encoding the CD40 ligand (CD40L) expressed on activated T cells. Prenatal genotyping in carriers with twin pregnancies is more challenging than in women with singleton pregnancies. In addition, women with twin pregnancies may decide on selective termination for which the risk of loss of the healthy foetus may exceed 7%. We report here on a family affected by XHIGM. Diagnosis of the disease was made in a male patient as late as 33 years of age. After family screening, the sister of the proband conceived male twins in two consecutive pregnancies. In the first pregnancy, one of the male foetuses was hemizygous for the c.521A>G (Q174R) mutation in the CD40L gene. In the second pregnancy, ultrasound scan showed one foetus to have exencephaly and karyotyping revealed this foetus to have trisomy 18. Several options were discussed, but the parents decided on selective termination in both pregnancies. The interventions were successful in both cases, and the mother now has two healthy sons. This report demonstrates the way in which advanced technologies in molecular medicine and obstetric interventions may assist families with decisions about possible selective termination in case of life-threatening molecular or chromosomal disorders. Diagnosis of CD40L deficiency at the age of 33 years in the proband was striking and indicated that PIDs are still neglected as disease entities in the evaluation of patients with recurrent severe infectious diseases.
Assuntos
Ligante de CD40/deficiência , Síndrome de Imunodeficiência com Hiper-IgM Tipo 1/diagnóstico , Síndrome de Imunodeficiência com Hiper-IgM Tipo 1/genética , Gravidez de Gêmeos/genética , Trissomia/diagnóstico , Trissomia/genética , Aborto Eugênico , Adulto , Ligante de CD40/genética , Ligante de CD40/imunologia , Cromossomos Humanos Par 18/genética , Cromossomos Humanos Par 18/imunologia , Diagnóstico Tardio , Feminino , Idade Gestacional , Humanos , Síndrome de Imunodeficiência com Hiper-IgM Tipo 1/imunologia , Síndrome de Imunodeficiência com Hiper-IgM Tipo 1/patologia , Recém-Nascido , Cariotipagem , Masculino , Mutação , Linhagem , Gravidez , Gravidez de Gêmeos/imunologia , Diagnóstico Pré-Natal , Linfócitos T/imunologia , Linfócitos T/patologia , Trissomia/imunologia , Trissomia/patologia , Síndrome da Trissomía do Cromossomo 18RESUMO
Immunoglobulin (Ig) A deficiency has long been recognized in patients with chromosome 18 abnormalities. We present the case of a young girl in whom a chromosome 18p deletion syndrome (46,XX,del[18][p11.1]) was associated not only with IgA deficiency, but also with an inability to make antibody to the unconjugated pneumococcal polysaccharide vaccine, Pneumovax II, indicating a concomitant specific polysaccharide antibody deficiency. The patient suffered from recurrent upper respiratory tract and genitourinary infections, which were controlled by the use of prophylactic antibiotics. The association of specific polysaccharide antibody deficiency, IgA deficiency, and chromosome 18p deletion syndrome has not been described previously, and extends the immunological phenotype of antibody deficiencies associated with defects of chromosome 18. The presence of specific polysaccharide antibody deficiency should be investigated in patients with chromosome 18 abnormalities, as these patients may have a more severe spectrum of infections than patients with chromosome 18 abnormalities and selective IgA deficiency alone.
Assuntos
Aberrações Cromossômicas , Deleção Cromossômica , Cromossomos Humanos Par 18/imunologia , Deficiência de IgA/genética , Polissacarídeos Bacterianos/imunologia , Anticorpos Antibacterianos/biossíntese , Criança , Feminino , Humanos , Deficiência de IgA/imunologia , Vacinas Pneumocócicas/imunologia , Polissacarídeos Bacterianos/genética , SíndromeRESUMO
NKT cells play a critical role in shaping the character and strength of a wide range of immune responses, including those against pathogens, tumours, allografts and autologous tissues. Because numbers of NKT cells affect clinical outcomes in a wide range of disease models, and this characteristic demonstrates allelic variation, the mapping of the locations and identification of the coding sequences of these genes has become a matter of significant importance. Here, we review the results to date that examine the effects of targeted deletion of a number of candidate genes, as well as the congenic and genetic linkage analyses that have attempted to localize allelic loci that affect NKT cell numbers. Although a number of candidate genes have been examined, there is no evidence that any of these contribute to variation in NKT cell numbers in natural populations. Two of the most important genetic regions controlling NKT cell numbers are Nkt1 on chromosome 1, which may contribute to lupus susceptibility, and Nkt2 on chromosome 2, which appears to contribute to diabetes susceptibility. Of great interest is a third locus on chromosome 18, identified in a novel congenic line, which can confer an absolute deficiency in this important immunoregulatory lymphocyte population.
Assuntos
Cromossomos Humanos Par 18/genética , Cromossomos Humanos Par 1/genética , Cromossomos Humanos Par 2/genética , Predisposição Genética para Doença , Células Matadoras Naturais , Ativação Linfocitária/genética , Linfócitos T , Doenças Autoimunes/genética , Doenças Autoimunes/imunologia , Contagem de Células , Cromossomos Humanos Par 1/imunologia , Cromossomos Humanos Par 18/imunologia , Cromossomos Humanos Par 2/imunologia , Doenças Transmissíveis/genética , Doenças Transmissíveis/imunologia , Humanos , Células Matadoras Naturais/citologia , Células Matadoras Naturais/imunologia , Ativação Linfocitária/imunologia , Neoplasias/genética , Neoplasias/imunologia , Linfócitos T/citologia , Linfócitos T/imunologia , Transplante HomólogoRESUMO
Human germinal center B cell tumors retain the ability of their nontransformed counterparts to somatically hypermutate Ig V genes by nucleotide substitution. Among a survey of 60 primary previously untreated, clonal, follicular lymphomas we have identified a rare V(H) rearrangement variant and two other in-frame nucleotide insertion/deletion variants within complementarity-determining region III of the Ig heavy chain. The neoplastic origin of the V(H) rearrangement variant was directly demonstrated in cells isolated by microdissection from malignant follicles. In all three cases a common clonal origin for the variants was demonstrated by complementarity-determining region III nucleotide sequence homology and shared somatic mutations in germline encoded positions in framework region IV. The monoclonal nature of the tumors was independently confirmed by demonstrating a single t(14;18) translocation breakpoint in the two cases with a detectable translocation. All the variants occurred in functional V(H) rearrangements, which in two cases were directly shown to encode functional Ab molecules. Both recombination-activating genes 1 and 2 were expressed in lymph node tumor cells containing the V(H) rearrangement variant, although recombination-activating gene expression among a panel of lymphomas was not limited to this variant.
Assuntos
Regiões Determinantes de Complementaridade/genética , Rearranjo Gênico de Cadeia Pesada de Linfócito B , Cadeias Pesadas de Imunoglobulinas/genética , Linfoma Folicular/genética , Linfoma Folicular/imunologia , Mutagênese Insercional/imunologia , Fases de Leitura/imunologia , Deleção de Sequência/imunologia , Sequência de Aminoácidos , Linfócitos B/imunologia , Linfócitos B/metabolismo , Linfócitos B/patologia , Sequência de Bases , Separação Celular , Cromossomos Humanos Par 14/genética , Cromossomos Humanos Par 14/imunologia , Cromossomos Humanos Par 18/genética , Cromossomos Humanos Par 18/imunologia , Células Clonais , Regiões Determinantes de Complementaridade/biossíntese , Impressões Digitais de DNA , Proteínas de Ligação a DNA/biossíntese , Proteínas de Ligação a DNA/genética , Amplificação de Genes , Genes de Imunoglobulinas , Variação Genética/imunologia , Proteínas de Homeodomínio/biossíntese , Proteínas de Homeodomínio/genética , Humanos , Cadeias J de Imunoglobulina/genética , Região Variável de Imunoglobulina/genética , Linfoma Folicular/patologia , Dados de Sequência Molecular , Proteínas Nucleares , RNA Mensageiro/biossíntese , Fases de Leitura/genética , Análise de Sequência de DNA , Translocação Genética , Transposases/genéticaRESUMO
Previous reports of an association between constitutional chromosome 18 abnormalities and low levels of IgA suggested that this chromosome contains a susceptibility locus for selective IgA deficiency (IgAD), the most frequent Ig deficiency in humans. IgAD is genetically related to common variable immunodeficiency (CVID), characterized by a lack of additional isotypes. Our previous linkage analysis of 83 multiple-case IgAD/CVID families containing 449 informative pedigree members showed a significantly increased allele sharing in the chromosome region 6p21 consistent with allelic associations in family-based and case-control studies and provided the evidence for a predisposing locus, termed IGAD1, in the proximal part of the MHC. We have typed the same family material at 17 chromosome 18 marker loci with the average intermarker distance of 7 cM. A total of 7633 genotypes were analyzed in a nonparametric linkage analysis, but none of the marker loci exhibited a significantly increased allele sharing in affected family members. In addition, reverse painting and deletion mapping of a panel of constitutional chromosome 18 deletions/translocations showed the presence of IgA-deficient and IgA-proficient patients with the same abnormality and did not reveal a region commonly deleted. The linkage analysis of chromosome 8 and 21 regions involved in reciprocal translocations t(8;18) and t(18;21), which were identified in two patients lacking IgA, did not disclose a significant allele sharing. Although these results do not exclude the presence of a minor predisposing locus on this chromosome, such a putative locus would confer a population risk of developing IgAD/CVID much lower than IGAD1.
Assuntos
Cromossomos Humanos Par 18/genética , Predisposição Genética para Doença/imunologia , Deficiência de IgA/genética , Meiose/genética , Estudos de Casos e Controles , Aberrações Cromossômicas/sangue , Aberrações Cromossômicas/genética , Aberrações Cromossômicas/imunologia , Transtornos Cromossômicos , Mapeamento Cromossômico , Cromossomos Humanos Par 18/imunologia , Feminino , Deleção de Genes , Ligação Genética/imunologia , Marcadores Genéticos , Humanos , Deficiência de IgA/sangue , Imunoglobulina A/sangue , Masculino , Meiose/imunologia , Translocação Genética/imunologiaRESUMO
There is a wide spectrum of lymphoid hyperplasias and neoplasias that may arise in salivary gland tissue. Some lesions arise in the extranodal mucosal-associated lymphoid tissue (MALT) located in the salivary gland; others arise within the lymph nodes embedded in the gland parenchyma. It is difficult to distinguish the site and cell of origin in many salivary gland lymphoid lesions, but recent advances in the identification of specific gene rearrangements in lymphomas corresponding to normal follicular center cells have provided a molecular marker for these tumors. The genes involved are the immunoglobulin heavy chain gene (located on chromosome 14) and the blc-2 gene (located on chromosome 18). This specific chromosomal translocation [t(14;18)] has been sought in extranodal lymphomas of skin, stomach, and intestine. To date, primary lymphomas in these sites have lacked the t(14;18) translocation. We investigated the t(14;18) using molecular techniques in a series of morphologically and immunophenotypically defined malignant non-Hodgkin's lymphomas presenting in the salivary gland. Of the seven cases we examined, three had molecular evidence of a t(14;18) translocation. All three lesions had a nodular growth pattern. The four cases lacking bcl-2 rearrangement had diffuse growth patterns. In addition, all four bcl-2 germline cases had morphologic or clinical findings consistent with a MALT origin. In contrast to the data published to date for primary lymphomas of the stomach, skin, and intestine, our findings indicate that salivary gland lymphomas frequently contain bcl-2 gene rearrangement. In addition, there appear to be differences in the clinical findings of bcl-2 rearranged and bcl-2 germline salivary gland lymphomas.